Gå till Affärer
Riskkapital | Hälsovård

Trust Chemists and Druggists Private Limited has raised equity

Trust Chemists and Druggists Private Limited has successfully completed an equity raise.

Founded in 2003, Trust Chemists and Druggists operates one of the largest hospital pharmacy chains in India. Specializing in managing in-hospital pharmacies, the company operates 47 in-hospital stores and 14 standalone stores across Karnataka, Tamil Nadu and Andhra Pradesh. It offers a one-stop shop for all medicines and wellness needs.

Oaklins’ team in India provided strategic and financial advisory services throughout this transaction. The team onboarded an investor, a family office, adding strategic value and contributing to financial growth. This investor acquired a 26% fully diluted stake in the investee.

Prata med transaktionsteamet

Vikas Dawra

Managing Partner
Mumbai, Indien
Oaklins India

Deepak Tulsian

Associate Director
Mumbai, Indien
Oaklins India

Relaterade affärer

UKAT Group has acquired Bayberry Limited
Riskkapital | Hälsovård

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Lär dig mer
Medicija has acquired Saulės Šeimos Medicinos Centras
Hälsovård

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Lär dig mer
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Hälsovård

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Lär dig mer